Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris:: A multicenter parallel group study

被引:13
作者
Emanuelsson, H
Egstrup, K
Nikus, K
Ellström, J
Glud, T
Pater, C
Scheibel, M
Tisell, A
Tötterman, KJ
Forsby, M
机构
[1] Sahlgrenska Hosp, Gothenburg, Sweden
[2] Svendborg Hosp, Svendborg, Denmark
[3] Jakobstad Hosp, Helsinki, Finland
[4] Sandviken Hosp, Sandviken, Sweden
[5] Middelfart Hosp, Middelfart, Denmark
[6] Hassleholm Hosp, Hasselholm, Sweden
[7] Kjellerup Hosp, Kjenerup, Denmark
[8] Vetlanda Hosp, Vetlanda, Sweden
[9] Deaconess Hosp, SF-00530 Helsinki, Finland
[10] Hassle Lakemedel AB, Molndal, Sweden
关键词
D O I
10.1016/S0002-8703(99)70409-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The primary objective of this randomized, double-blind, parallel group trial was to compare the antianginal and antiischemic efficacy of a combination tablet of felodipine-metoprolol 10/100 mg once daily with both drugs given separately once daily in patients with stable effort-induced angina pectoris. The secondary objective was to compare the tolerability of the 3 treatments. Methods The main criteria For inclusion were stable effort-induced angina pectoris For at least 2 months before the enrollment and a positive bicycle exercise test result. Patients were allocated to once-daily treatment with either felodipine-metoprolol 10/100 mg, Felodipine 10 mg, or metoprolol 100 mg. The duration of active double-blind treatment was 4 weeks. There were 3 primary efficacy variables in the study; time until end of exercise,time until onset of chest discomfort, and time until 1-mm ST depression during a standardized exercise test. Results:The number of patients randomized was 397. There was a statistically significant improvement in time until end of exercise with felodipine-metoprolol 10/100 mg compared with metoprolol 100 mg (P = .04) and felodipine 10 mg compared with metoprolol 100 mg (P = .03). However, for time until onset of pain or time until l-mm ST-depression there were no significant differences among the treatment groups. At highest comparable workload, ST depression was less pronounced with felodipine-metoprolol than with metoprolol alone (P = .04), and the rate-pressure product was significantly lower in the groups receiving felodipine-metoprolol and metoprolol than in the group receiving felodipine alone. The combination and metoprolol were better tolerated than Felodipine alone. Conclusions In stable angina pectoris, the combination felodipine-metoprodol 10/100 mg and felodipine 10 mg alone increased exercise time compared with metoprolol 100 mg. The combination tablet and metoprolol 100 mg alone showed a more Favorable tolerability profile than felodipine 10 mg alone.
引用
收藏
页码:854 / 862
页数:9
相关论文
共 24 条
[11]  
METCALFE MJ, 1989, BRIT HEART J, V61, P258
[12]   METOPROLOL-INDUCED REDUCTION IN POSTINFARCTION MORTALITY - POOLED RESULTS FROM 5 DOUBLE-BLIND RANDOMIZED TRIALS [J].
OLSSON, G ;
WIKSTRAND, J ;
WARNOLD, I ;
CATS, VM ;
MCBOYLE, D ;
HERLITZ, J ;
HJALMARSON, A ;
SONNENBLICK, EH .
EUROPEAN HEART JOURNAL, 1992, 13 (01) :28-32
[13]  
ORO L, 1981, ANN CLIN RES, V13, P58
[14]   Felodipine in addition to beta-adrenergic blockade for angina pectoris - A multicentre, randomized, placebo-controlled trial [J].
Ronnevik, PK ;
Silke, B ;
Ostergaard, O .
EUROPEAN HEART JOURNAL, 1995, 16 (11) :1535-1541
[15]   FELODIPINE IN CHRONIC STABLE ANGINA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY [J].
SANGIORGIO, P ;
DIPASQUALE, G ;
SAVONITTO, S ;
URBINATI, S ;
RUBBOLI, A ;
CAVALLOTTI, G ;
PINELLI, G ;
BRACCHETTI, D .
EUROPEAN HEART JOURNAL, 1990, 11 (11) :1011-1017
[16]   24-HOUR ACTIVITY OF FELODIPINE EXTENDED RELEASE IN CHRONIC STABLE ANGINA-PECTORIS [J].
SANTORO, G ;
SAVONITTO, S ;
DIBELLO, V ;
ALBERTI, D ;
GIUSTI, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (05) :457-462
[17]   Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris - Results of the International Multicenter AnGina Exercise (IMAGE) study [J].
Savonitto, S ;
Ardissino, D ;
Egstrup, K ;
Rasmussen, K ;
Bae, EA ;
Omland, T ;
SchjelderupMathiesen, PM ;
Marraccini, P ;
Wahlqvist, I ;
Merlini, PA ;
Rehnqvist, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) :311-316
[18]   ACUTE EFFECTS OF FELODIPINE IN EXERTIONAL ANGINA-PECTORIS [J].
SCARDI, S ;
PANDULLO, C ;
PIVOTTI, F ;
CESCHIA, G ;
POLLAVINI, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (10) :691-695
[19]   24 H ANTIANGINAL AND ANTIISCHEMIC EFFECTS WITH ONCE-DAILY FELODIPINE - A DOUBLE-BLIND COMPARISON WITH NIFEDIPINE, TWICE-DAILY, AND PLACEBO IN PATIENTS WITH STABLE EXERCISE-INDUCED ANGINA-PECTORIS [J].
SCHULTE, KL .
EUROPEAN HEART JOURNAL, 1995, 16 (02) :171-176
[20]   FELODIPINE IN ISCHEMIC HEART-DISEASE [J].
SHERIDAN, JV ;
THOMAS, P ;
SHERIDAN, DJ .
DRUGS, 1987, 34 :71-78